Prediction of maternal predisposition to preeclampsia

Hypertension in Pregnancy

Volumn 27, Issue 3, 2008, Pages 237-245

  Emonts, Patrick ^a   Seaksan, Sontera ^a   Seidel, Laurence ^a   Thoumsin, Henri ^a   Gaspard, Ulysse ^a   Albert, Adelin ^a   Foidart, Jean Michel ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Hypertension; Preeclampsia; Prenatal care; Screening; Thrombophilia

Indexed keywords

BLOOD CLOTTING FACTOR 8; HOMOCYSTEINE; PROTEIN S; THIAMINE;

ADULT; ANAMNESIS; ARTICLE; BLOOD CLOTTING; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; DEMOGRAPHY; DISEASE PREDISPOSITION; FAMILY HISTORY; FEMALE; HEMOSTASIS; HUMAN; HYPERTENSION; KIDNEY FUNCTION; LABORATORY TEST; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MEDICAL EXAMINATION; PARITY; PARTIAL THROMBOPLASTIN TIME; PLASMA VOLUME; PREDICTION; PREECLAMPSIA; PREGNANCY; PREVALENCE; PROBABILITY; PROTHROMBIN TIME; RISK ASSESSMENT; SCORING SYSTEM; STATISTICAL SIGNIFICANCE;

ADULT; BELGIUM; BLOOD VOLUME; CAUSALITY; FEMALE; HUMANS; PRE-ECLAMPSIA; PREGNANCY;

EID: 49549115330     PISSN: 10641955     EISSN: 15256065     Source Type: Journal    
DOI: 10.1080/10641950802000901     Document Type: Article

References (28)

1. Confidential Enquiries into Maternal Deaths. Why mothers die 1997-1999. The fifth report of the confidential enquiries into maternal deaths in the United Kingdom. London: Royal College of Obstetricians and Gynaecologists Press, 2001.
2. th annual report. London: Maternal and Child Health Research Consortium, 2001.
3. Walker ID. Thromphilias and preeclampsia In: Pre-eclampsia, Etiology and Practical Practice, Fiona Lyall and Michael Belfort, eds. Cambridge University Press, 2007, p. 183.
4. Sibai BM, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005; 365:785-799.
5. Ness RB, Roberts JM. Heterogeneous causes constituting the single syndrome of pre-eclampsia: a hypothesis and its implications. Am J Obstet Gynecol 1996; 175:1365-1370.
6. Audibert Fr. Screening for pre-eclampsia: the quest for the Holy Grail? Lancet 2005;365:1367-1379.
7. Tjoa ML, Oudejans CBM, Van Vugt JMG, Blankenstein MA, Van Wijk IJ. Markers for presymptomatic prediction of pre-eclampsia and intrauterine growth restriction. Hypertens Pregnancy 2004;23(2):171-189.
8. Conde-Agudelo A, Villar J, Lindheimer M. World Health Organization systematic review of screening tests for preeclampsia. Obstet Gynecol 2004;104(6): 1367-1391.
9. Sibai BM, Mercer B, Sarinoglu C. Severe preeclampsia in the second trimester: recurrence risk and long-term prognosis. Am J Obstet Gynecol 1991 Nov;165(5 Pt 1): 1408-1412.
10. Weinstein L. Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol 1982;142:159-167.
11. Walker ID. Thrombophilia in pregnancy. J Clin Pathol 2000;53:573-580.
12. Gates S. Thromboembolic disease in pregnancy. Cur Opin Obstet Gynecol 2000;12:117-122.
13. Walker JJ. Pre-eclampsia. Lancet 2000;356:1260-1265.
14. Alfirevic Z, Robets D, Martlew V. How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review. Eur J Obstet Gynecol Reprod Biol 2002;101(1):6-14.
15. Empson M, Lassere M, Craig JC, Scott JR (2002) Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials. Obstet Gynecol 2002;99;135-144.
16. Ghee CB, Burrows RF. Prothrombin G20210A mutation is not associated with recurrent miscarriages. Aust N Z J Obstet Gynecol 2002;42:167-169.
17. Morrison ER, Miedzybrodzka ZH, Campbell DM, Haites NE, Wilson BJ, Watson MS. Prothrombotic genotypes are not associated with pre-eclampsia and gestational hypertension: results from a large population-based study and systematic review. Thromb Haemost 2002;87:779-785.
18. Greer IA. Thrombophilia: implications for pregnancy outcome. Thromb Res 2003;2152:1-9.
19. Rey E, Kahn SR, David M, Shrier I. Thrombophilic disorders and fetal loss: a meta-analysis. Lancet 2003;361:901-908.
20. Lin J. Genetic Thrombophilias and pre-eclampsia: a meta-analysis. Am Coll Obstet Gynecol 2005;105:182-192.
21. Robertson L & coll. Thrombophilia in pregnancy: a systematic review. Br J Haematol 2006;132:171-186.
22. Cotter A, Molloy A, Scott JM, Daly SF. Elevated plasma homocysteine in early pregnancy: A risk factor for the development of severe preeclampsia. Presented at the 21st Annual Meeting of the Society of Maternal-Fetal Medicine, Reno, Nevada. February 5-10, 2001.
23. Sibai BM. Hypertensive Disorders in Women. Philadelphia: W.B. Saunders Company 2001;1001.
24. Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ 2005;330:565-571.
25. Chesley LC. Plasma and red cell volumes during pregnancy. Am J Obstet Gynecol 1972;112:440-450.
26. Silver HM, Seebeck MA, Carlson R. Comparison of total volume in normal, preeclamptic, and non proteinuric gestational hypertensive pregnancy by subcutaneous measurement of red blood cell and plasma volume. Am J Obstet Gynecol 1998;179:87-93.
27. Cunningham FG, Gant NF, Leveno KJ, GilstrapLC, Hauth JC, Wenstrom KD. Hematological Changes: Maternal adaptations to pregnancy (chapter 8) : Physiology of Pregnancy (section II); In Williams Obstetrics, 21st Edition, New York: McGraw-Hill. 2001, pp 177-178.
28. Myatt L, Carpenter LB. Prediction of preeclampsia, In: Pre-eclampsia, Etioloy and Clinical Practice, E. Fiona Lyall and Michael Belfort, eds. Chapter 15, Cambridge: Cambridge University Press, 2007; p. 226.